The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 trial to evaluate the efficacy and safety of WZTL-002, a third-generation anti-CD19 CAR T-cell therapy, in patients with relapsed or refractory large B-cell lymphoma (ENABLE-2).
 
Aine Hurley
No Relationships to Disclose
 
Philip George
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie
 
Giulia Giunti
Employment - BioOra
 
Brittany Lavender
No Relationships to Disclose
 
Amy Holmes
Employment - Canterbury District Health Board
 
Clinton Lewis
No Relationships to Disclose
 
Robert Weinkove
Consulting or Advisory Role - BeiGene; Janssen; MSD Avenir
Speakers' Bureau - Abbvie; Janssen
Patents, Royalties, Other Intellectual Property - Novel CD20 Protein NZ795049